The global Rare Biological Sample Collection market size is predicted to grow from US$ 39250 million in 2025 to US$ 64060 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
A "Rare Biological Sample Collection" refers to a curated assembly of biological specimens that are considered uncommon, unique, or infrequently encountered in nature. These samples could include various types of organisms, tissues, cells, or genetic materials that are not easily accessible or are rare in their occurrence.
Implementation of advanced biobanking technologies for the preservation and storage of rare biological samples. This may include improved cryopreservation methods, automated sample handling systems, and enhanced tracking and monitoring technologies.
LPI (LP Information)' newest research report, the “Rare Biological Sample Collection Industry Forecast” looks at past sales and reviews total world Rare Biological Sample Collection sales in 2024, providing a comprehensive analysis by region and market sector of projected Rare Biological Sample Collection sales for 2025 through 2031. With Rare Biological Sample Collection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rare Biological Sample Collection industry.
This Insight Report provides a comprehensive analysis of the global Rare Biological Sample Collection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rare Biological Sample Collection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare Biological Sample Collection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare Biological Sample Collection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare Biological Sample Collection.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare Biological Sample Collection market by product type, application, key players and key regions and countries.
Segmentation by Type:
Isolation Kits & Reagent
Blood Collection Tubes
Others
Segmentation by Application:
Oncology
Transcriptomics
Pharmacogenomics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Miltenyi Biotec
F.Hoffmann-La RocheLtd.
QIAGEN
STRECK
CreatvMicroTech, Inc.
Genetix
Creative-Bioarray
Amgen Inc.
Agena Bioscience
Bio-Rad Laboratories, Inc.
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook